-
K.
Dyet,
D.
Martin
(2005)
Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic
Epidemiology and Infection, 134
-
C.
Fijen,
E.
Kuijper,
M.
Drogari-Apiranthitou,
M.
LeeuwenvanY.,
M.
Daha,
J.
Dankert
(1998)
Protection against meningococcal serogroup ACYW disease in complement‐deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine
Clinical & Experimental Immunology, 114
-
L.
Carlsson,
S.
Santoso,
Gudrun
Baurichter,
H.
Kroll,
Stephanie
Papenberg,
P.
Eichler,
N.
Westerdaal,
V.
Kiefel,
J.
Winkel,
A.
Greinacher
(1998)
Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
Blood, 92 5
-
R.
Borrow,
P.
Balmer,
E.
Miller
(2005)
Meningococcal surrogates of protection--serum bactericidal antibody activity.
Vaccine, 23 17-18
-
(2008)
Vaccines, 5th ed
-
R.
Borrow,
G.
Carlone,
N.
Rosenstein,
M.
Blake,
I.
Feavers,
D.
Martin,
W.
Zollinger,
J.
Robbins,
I.
Aaberge,
D.
Granoff,
Elizabeth
Miller,
B.
Plikaytis,
L.
Alphen,
J.
Poolman,
R.
Rappuoli,
L.
Danzig,
J.
Hackell,
B.
Danve,
M.
Caulfield,
S.
Lambert,
D.
Stephens
(2006)
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.
Vaccine, 24 24
-
J.
Russell,
K.
Jolley,
I.
Feavers,
M.
Maiden,
J.
Suker
(2004)
PorA Variable Regions of Neisseria meningitidis
Emerging Infectious Diseases, 10
-
A.
Platonov,
I.
Vershinina,
H.
Käyhty,
C.
Fijen,
R.
Würzner,
E.
Kuijper
(2003)
Antibody-Dependent Killing of Meningococci by Human Neutrophils in Serum of Late Complement Component-Deficient Patients
International Archives of Allergy and Immunology, 130
-
J.
Fredriksen,
E.
Rosenqvist,
E.
Wedege,
K.
Bryn,
G.
Bjune,
F.
Lo,
Lindbak
Ak,
B.
Møgster,
E.
Namork,
U.
Rye
(1991)
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.
NIPH annals, 14 2
-
S.
Ross,
P.
Rosenthal,
H.
Berberich,
P.
Densen
(1987)
Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals.
The Journal of infectious diseases, 155 6
-
(2008)
Meningoccal vaccines
-
C.
Fijen,
E.
Kuijper,
H.
Tjia,
M.
Daha,
J.
Dankert
(1994)
Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 18 5
-
P.
Balmer,
R.
Borrow
(2004)
Serologic correlates of protection for evaluating the response to meningococcal vaccines
Expert Review of Vaccines, 3
-
C.
Fijen,
A.
Hannema,
E.
Kuijper,
A.
Sjöholm,
Jos
Putten
(1989)
COMPLEMENT DEFICIENCIES IN PATIENTS OVER TEN YEARS OLD WITH MENINGOCOCCAL DISEASE DUE TO UNCOMMON SEROGROUPS
The Lancet, 334
-
J.
Findlow,
Stephen
Taylor,
A.
Aase,
R.
Horton,
R.
Heyderman,
J.
Southern,
N.
Andrews,
R.
Barchha,
E.
Harrison,
Ann
Lowe,
E.
Boxer,
C.
Heaton,
P.
Balmer,
E.
Kaczmarski,
P.
Oster,
A.
Gorringe,
R.
Borrow,
E.
Miller
(2006)
Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac
Infection and Immunity, 75
-
G.
Bjune,
Høiby
Ea,
Grønnesby
Jk,
Øyvind
Arnesen,
J.
Fredriksen,
A.
Lindbak,
H.
Nøkleby,
E.
Rosenqvist,
L.
Solberg,
O.
Closs,
F.
Lo,
A.
Lystad,
L.
Bakketeig,
B.
Hareide,
A.
Halstensen,
E.
Holten,
J.
Eng
(1991)
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
The Lancet, 338
-
J.
Figueroa,
J.
Andreoni,
P.
Densen
(1993)
Complement deficiency states and meningococcal disease
Immunologic Research, 12
-
G.
Spickett
(1998)
Complement: A Practical Approach.
Journal of Clinical Pathology, 51
-
R.
Würzner,
A.
Orren,
P.
Potter,
B.
Morgan,
D.
Ponard,
P.
Späth,
M.
Brai,
M.
Schulze,
L.
Happe,
O.
Götze
(1991)
Functionally active complement proteins C6 and C7 detected in C6‐ and C7‐deficient individuals
Clinical & Experimental Immunology, 83
-
N.
Andrews,
R.
Borrow,
E.
Miller
(2003)
Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England
Clinical and Vaccine Immunology, 10
-
I.
Goldschneider,
E.
Gotschlich,
M.
Artenstein
(1969)
HUMAN IMMUNITY TO THE MENINGOCOCCUS
The Journal of Experimental Medicine, 129
-
E.
Rosenqvist,
E.
HØIby,
E.
Wedege,
Klaus
Bryn,
Jan
Kolberg,
A.
Klem,
Elisabet
Rønnild,
Gunnar
Bjune,
Hanne
Nøkleby
(1995)
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine
Infection and Immunity, 63
-
J.
Figueroa,
P.
Densen
(1991)
Infectious diseases associated with complement deficiencies
Clinical Microbiology Reviews, 4
-
A.
Platonov,
I.
Vershinina,
E.
Kuijper,
R.
Borrow,
H.
Käyhty
(2003)
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine.
Vaccine, 21 27-30
-
A.
Dodds,
Robert
Sim
(1997)
Complement : a practical approach
-
A.
Platonov,
V.
Beloborodov,
I.
Vershinina
(1993)
Meningococcal Disease in Patients with Late Complement Component Deficiency: Studies in the U.S.S.R
Medicine, 72
-
(2003)
HUMAN IMMUNITY TO THE MENINGOCOCCUS I . THE ROLE OF HUMORAL ANTIBODIES
-
C.
Trotter,
J.
Findlow,
P.
Balmer,
A.
Holland,
R.
Barchha,
N.
Hamer,
N.
Andrews,
E.
Miller,
R.
Borrow
(2007)
Seroprevalence of Bactericidal and Anti-Outer Membrane Vesicle Antibodies to Neisseria meningitidis Group B in England
Clinical and Vaccine Immunology, 14
-
C.
Frasch,
W.
Zollinger,
J.
Poolman
(1985)
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.
Reviews of infectious diseases, 7 4
-
Bradley
Perkins,
K.
Jónsdóttir,
H.
Briem,
E.
Griffiths,
B.
Plikaytis,
E.
Høiby,
E.
Rosenqvist,
J.
Holst,
H.
Nøkleby,
F.
Sotolongo,
G.
Sierra,
H.
Campa,
G.
Carlone,
D.
Williams,
Janet
Dykes,
D.
Kapczynski,
E.
Tikhomirov,
J
Wenger,
C.
Broome
(1998)
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.
The Journal of infectious diseases, 177 3
-
J.
Andreoni,
H.
Käyhty,
P.
Densen
(1993)
Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals.
The Journal of infectious diseases, 168 1
-
J.
Tappero,
R.
Lagos,
Aurora
Ballesteros,
B.
Plikaytis,
Derrick
Williams,
Janet
Dykes,
L.
Gheesling,
G.
Carlone,
E.
Høiby,
J.
Holst,
H.
Nøkleby,
E.
Rosenqvist,
Gustavo
Sierra,
C.
Campa,
F.
Sotolongo,
Jeanette
Vega,
Julio
Garcia,
P.
Herrera,
J.
Poolman,
B.
Perkins
(1999)
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
JAMA, 281 16
-
M.
Pizza,
V.
Scarlato,
V.
Masignani,
M.
Giuliani,
B.
Aricó,
M.
Comanducci,
G.
Jennings,
L.
Baldi,
E.
Bartolini,
B.
Capecchi,
C.
Galeotti,
E.
Luzzi,
R.
Manetti,
E.
Marchetti,
Marirosa
Mora,
S.
Nuti,
G.
Ratti,
L.
Santini,
S.
Savino,
M.
Scarselli,
E.
Storni,
P.
Zuo,
Michael
Broeker,
E.
Hundt,
Bernard
Knapp,
E.
Blair,
T.
Mason,
Hervé
Tettelin,
D.
Hood,
A.
Jeffries,
N.
Saunders,
D.
Granoff,
J.
Venter,
E.
Moxon,
G.
Grandi,
R.
Rappuoli
(2000)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
Science, 287 5459
-
M.
Fischer,
G.
Carlone,
J.
Holst,
D.
Williams,
D.
Stephens,
B.
Perkins
(1999)
Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
Vaccine, 17 19
-
J.
Welsch,
G.
Moe,
R.
Rossi,
J.
Adu‐Bobie,
R.
Rappuoli,
D.
Granoff
(2003)
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
The Journal of infectious diseases, 188 11
-
J.
Welsch,
D.
Granoff
(2007)
Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal Antibody
Clinical and Vaccine Immunology, 14